Brighton Jones’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$150K Sell
37,744
-2,137
-5% -$8.92K ﹤0.01% 1292
2026
Q2
$168K Sell
39,881
-158
-0.4% -$609 ﹤0.01% 1270
2026
Q1
$141K Buy
+40,039
New +$164K ﹤0.01% 1113
2025
Q4
– Sell
-33,071
Closed -$43.3K – 493
2025
Q3
$43.3K Buy
33,071
+2,646
+9% +$2.74K ﹤0.01% 1008
2025
Q2
$21.8K Buy
+30,425
New +$23.9K ﹤0.01% 917

Other funds holding IRWD

Brighton Jones's IRWD Position: Q3 2026 in Review

Brighton Jones reduced its Ironwood Pharmaceuticals (IRWD) stake by 5.4% in Q3 2026, selling an estimated $8.92K and leaving 37,744 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

Brighton Jones first reported a position in IRWD in Q2 2025 and has held it in 5 quarters since. The position peaked at $168K in Q2 2026. 191 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Brighton Jones held 37,744 shares of Ironwood Pharmaceuticals worth $150K as of Q3 2026.
  • Brighton Jones sold 2,137 Ironwood Pharmaceuticals shares in Q3 2026, an estimated $8.92K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1292 holding.
  • Brighton Jones first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Brighton Jones's Ironwood Pharmaceuticals position peaked at $168K in Q2 2026.
  • 191 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.